Meniscectomy
14
0
0
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
2 terminated out of 14 trials
83.3%
-3.3% vs benchmark
21%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (14)
Verifying the Effectiveness of the NUsurface® System
Needle Arthroscopy vs Conventional Arthroscopy in Knees
Can Tendon Autograft Function As a Meniscal Transplant
Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy
Telerehabilitation Following Meniscectomy
Impact of Physiotherapy on Short-term Outcome After Meniscectomy
Short Term Outcome After Meniscectomy
The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)
AIR (Artificial Implant for Medial Meniscus Replacement) Study
Saphenous Nerve Block for Partial Meniscectomy
Biomechanical Osteoarthritis Outcomes in Meniscectomy Patients
Dose Response of Ketorolac in Knee Arthroscopy
Muscle Weakness and Post-traumatic Knee OA
Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations